PeptideStack
5.2kquestions
20kanswers
220users

How do I trace an SSA lot number back to a synthesis date?

Asked 30 May 2026Modified 1 min agoViewed 6.6k times
11

I have the report as a PDF with the chromatogram on page two, so I can quote specifics.

I want a method I can write down and repeat, not a rule of thumb.

I would rather over-engineer this than discover a problem later, within reason.

Which parts of this are load-bearing and which parts are habit?

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

436 questions
shareeditfollowflag
ED
askede_dziedzic87k24830 May 2026
7Worth flagging that this changed in 2025, so older answers on the site are out of date. – mateo_iglesias 3 months ago
add a comment

3 Answers

Accepted answer first, then by votes
31

Accepted answer

Concretely, the practical consequence is that spot-testing one vial from a new supplier is better than assuming they are all the same.

The statistical foundation here is well-established, which is why sampling plans from decades ago are still valid.

Stratified sampling — testing one vial from the top, one from the middle, and one from the bottom of a shipment — is cheap insurance against segregation.

Sampling plans for pharmaceutical manufacturing are defined in ISO 2859 and ANSI Z1.4, and they are based on statistical sampling theory.

I would treat a "complies with" statement without sampling details as a claim rather than as evidence.

Assume segregation is possible, and design your sampling to catch it if it exists.

shareimprove this answerflag
GI
answered · acceptedgunnar_isaksen16k2823 Jul 2026
7I have seen exactly this failure mode twice and both times it was the diluent. – b_delacroix 7 months ago
6The distinction between purity and content cannot be repeated often enough here. – tandem_gradient 5 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
24

Most suppliers test one vial per lot and report the result as lot homogeneity, which is sampling one item from one lot and extrapolating wildly.

Under AQL sampling plans, testing two vials from a fifty-vial lot gives you an operating characteristic curve that tells you what risks you are accepting.

The sample size determination requires choosing a confidence level and an acceptable error rate, and the smaller the error rate you want, the larger your sample must be.

Worth noting that thermal excursions during shipping affect different vials differently, so the lot may not be homogeneous even if it left the factory that way.

If testing multiple vials, state how many you tested and why you chose those vials.

edited 8 Aug 2026 by m_haraldsen — reworded for clarity after a comment

shareimprove this answerflag
MH
answeredm_haraldsen38k3823 Jul 2026
11

Specifically, batch testing establishes what can be claimed about the lot as a whole, and the sample size determines how much you can actually claim.

A statement that "lot 20260412 complies with specifications" is meaningless without stating which vials from the lot were tested and how many there were.

On the detail: if the lot was manufactured in multiple batches, testing vials from each batch separately establishes whether batch-to-batch variation is acceptable.

Lyophilised peptide homogeneity studies show that vial-to-vial variation is usually small but occasionally large, depending on the distribution in the freeze-dryer.

One qualification: testing more vials gives better confidence, but at some point the cost outweighs the benefit.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

shareimprove this answerflag
MT
answeredmarcus_thorbjorn16k2823 Jul 2026
6The distinction between purity and content cannot be repeated often enough here. – Dr_Signe_Baldursdottir 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.